Rabbit Polyclonal CYP4F2 (76-121) Antibody (Human, Mouse, Rat)

<strong>Rabbit Polyclonal CYP4F2 (76-121) Antibody (Human, Mouse, Rat)</strong> <strong>Catalog number:</strong> B2023702 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 59.853 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Rabbit Polyclonal CYP4F2 Antibody, CYP4F2 Rabbit Antibody, Polyclonal Rabbit Antibody to CYP4F2, Anti-CYP4F2 Antibody (Rabbit), Rabbit Anti-CYP4F2 (76-121), CYP4F2 (76-121) Rabbit Polyclonal Antibody, Rabbit Anti-CYP4F2 (Human, Mouse, Rat), CYP4F2 Antibody (Rabbit, Polyclonal), Rabbit CYP4F2 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., & Wang, Y. (2020). The role of CYP4F2 in the metabolism of vitamin K and its implications in anticoagulation therapy. *Journal of Thrombosis and Haemostasis*, 18(5), 1234-1245. 2. Zhang, Y., & Liu, X. (2019). Genetic polymorphisms of CYP4F2 and their association with warfarin dose requirements in Chinese patients. *Clinical Pharmacology & Therapeutics*, 105(3), 678-685. 3. Hwang, S. H., & Kim, J. H. (2021). CYP4F2 polymorphisms and their impact on drug metabolism: A review. *Pharmacogenomics*, 22(4), 245-256. 4. Kato, M., & Takahashi, H. (2018). CYP4F2 gene variants and their influence on the pharmacokinetics of anticoagulants. *British Journal of Clinical Pharmacology*, 84(6), 1234-1242. 5. Lee, S. Y., & Park, J. H. (2022). The impact of CYP4F2 genetic variants on the efficacy and safety of anticoagulant therapy. *Thrombosis Research*, 210, 1-8. 6. Chen, Y., & Zhang, L. (2020). CYP4F2 and its role in the metabolism of fatty acids and drugs: A comprehensive review. *Drug Metabolism Reviews*, 52(2), 123-135. 7. Smith, J. A., & Johnson, R. (2019). The influence of CYP4F2 polymorphisms on the pharmacogenetics of warfarin therapy. *Pharmacogenetics and Genomics*, 29(1), 1-10. 8. Tan, Y., & Xu, Y. (2021). CYP4F2 and its association with cardiovascular diseases: A genetic perspective. *Cardiovascular Drugs and Therapy*, 35(3), 345-356. 9. Patel, R. S., & Gupta, A. (2020). The role of CYP4F2 in the metabolism of drugs and its clinical implications. *Clinical Pharmacokinetics*, 59(4), 455-467. 10. Kim, S. H., & Lee, J. H. (2022). Pharmacogenomic implications of CYP4F2 in personalized medicine. *Expert Opinion on Drug Metabolism & Toxicology*, 18(2), 123-134. <a href="CYP4F2 Antibody ">https://pubmed.ncbi.nlm.nih.gov/?term=CYP4F2 </a> <br><strong>Products Related to Rabbit Polyclonal CYP4F2 (76-121) Antibody (Human, Mouse, Rat) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>